Rubicon Research IPO: The initial public offering (IPO) of Rubicon Research Limited entered its second day of public bidding today, October 10, with the issue subscribed 74 per cent so far, as per provisional exchange data. The pharmaceutical formulations company aims to raise Rs 1377.50 crore from the public offering of 2.84 crore equity shares….
Rubicon Research IPO: The initial public offering (IPO) of Rubicon Research Limited opened today, October 9 and will remain open for public bidding till October 13, 2025. The pharmaceutical formulations company aims to raise around Rs 1377.50 crore from the public offering of 2.84 crore equity shares. The issue was subscribed 51 per cent at the end…
Rubicon Research, a General Atlantic-promoted pharma company, is all set to launch its Rs 1,377.5-crore initial public offering (IPO) on October 9, joining the wave of major public issues next week alongside Tata Capital’s Rs 15,512-crore IPO and LG Electronics India’s Rs 11,607-crore offering. The anchor book for the IPO will open for a single…